New Conformable P-Type $(3+1)$-Dimensional Evolution Equation and its Analytical and Numerical Solutions
Journal of New Theory · 29.03.2024 · (46) · 71-88
DOI: 10.53570/jnt.1420224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of New Theory, online erschienen am 29.03.2024. Verfasst von Mehmet Şenol und 1 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Nevşehir Hacı Bektaş Veli University..
Abstract (Originalsprache)
The paper examines the conformable nonlinear evolution equation in $(3+1)$-dimensions. First, basic definitions and characteristics for the conformable derivative are given. Then, the modified extended tanh-function and $\exp(–\phi(\xi))$-expansion techniques are utilized to determine the exact solutions to this problem. The consequences of some of the acquired data's physical 3D and 2D contour surfaces are used to demonstrate the findings, providing insight into how geometric patterns are physically interpreted. These solutions help illustrate how the studied model and other nonlinear representations in physical sciences might be used in real-world scenarios. It is clear that these methods have the capacity to solve a large number of fractional differential equations with beneficial outcomes.
Förderung
- Nevşehir Hacı Bektaş Veli University.
Zitieren
APA
Şenol, M., & Erol, M. Ö. (2024). New Conformable P-Type $(3+1)$-Dimensional Evolution Equation and its Analytical and Numerical Solutions. Journal of New Theory, 71-88. https://doi.org/10.53570/jnt.1420224
Vancouver
Şenol M, Erol MÖ. New Conformable P-Type $(3+1)$-Dimensional Evolution Equation and its Analytical and Numerical Solutions. Journal of New Theory. 2024:71-88. doi:10.53570/jnt.1420224
BibTeX
@article{enol2024,
author = {Şenol, Mehmet and Erol, Meliha Özlem},
title = {New Conformable P-Type $(3+1)$-Dimensional Evolution Equation and its Analytical and Numerical Solutions},
journal = {Journal of New Theory},
year = {2024},
number = {46},
pages = {71--88},
doi = {10.53570/jnt.1420224}
}
EUVIMED